1,987 items · By date added

Morgan Stanley: China’s pharmaceutical exports grow, but pressure on API prices persists

Pharmaceutical exports rose 10.5% year on year in the first three quarters of 2026, but the trade deficit still widened to 21 billion US dollars. Morgan Stanley says excess capacity and low utilization continue to suppress active pharmaceutical ingredient (API) prices, prompting some manufacturers to move into finished formulations or CDMO services.

Morgan Stanley: Sinoma Science & Technology’s third-quarter profit rises 46% year on year, broadly flat quarter on quarter

Higher glass fiber volumes and prices, together with higher lithium-ion battery separator volumes and prices in the third quarter, improved Sinoma Science & Technology’s profitability in the first three quarters. However, third-quarter revenue and net profit were both broadly flat quarter on quarter, and Morgan Stanley viewed the results as slightly below market consensus.

Yahoo's Market Hang discussion: GPUs sitting in warehouses without power and the same AI trade

In this episode of Yahoo's Market Hang, the hosts and guests including KraneShares Chief Investment Officer Brendan Ahern and Raymond James Chief Market Strategist Matt Orton start with the 261-page Anthropic S-1 and discuss hundreds of millions of dollars' worth of GPUs sitting in warehouses without power, the grid's inability to keep up as the real bottleneck, and how everyone is effectively in the same AI trade.

CNA interview: ARK’s Winton says Anthropic’s strong growth can support its high valuation

Brett Winton, chief futurist at ARK Invest, speaks with CNA’s Asia First: ARK’s venture capital fund has held a stake in Anthropic for years. He believes Anthropic’s annualized revenue could exceed 100 billion dollars by year-end, frontier labs could generate a combined 3 trillion dollars in revenue by 2030 to 2031, and the 8 billion dollar loss is merely a fair-value adjustment on convertible bonds.

Bloomberg “The China Show” interview: Goldman Sachs’ Lau says Chinese equity valuations have returned to lows seen before September 2024

Bloomberg “The China Show” guest segment: Goldman Sachs chief China equity strategist Kinger Lau discusses MSCI China trading at approximately 9 times forward earnings, back near its lows before September 2024; overall earnings are expected to grow approximately 10%, while profits in China’s AI sector grew 20% in the first half.

Bloomberg interview: BlackRock’s Rieder on 10-year Treasuries taking a back seat and AI financing as the main theme

Rick Rieder, BlackRock’s chief investment officer of global fixed income, speaks with Bloomberg’s The Asia Trade: demand for 10-year Treasuries is muted even as their yield approaches 5%; portfolios yielding around 7% can already be assembled at the front end of the curve, and the 60/40 portfolio is outdated. Secured single-A-rated technology bonds issued to finance GPUs and data centers are emerging as the most attractive new opportunity in the bond market.

Prof G Markets conversation: Kedrosky and Armstrong on Anthropic’s 800 billion-dollar commitments and potential triggers for a pullback

This episode of Prof G Markets is hosted by Ed Elson. Paul Kedrosky, managing partner at SK Ventures, breaks down Anthropic’s S-1 and notes that more than 800 billion dollars in computing commitments do not appear on its income statement. Financial Times US financial commentator Robert Armstrong then discusses whether the stock market could enter a pullback as the bond market demands increasingly high prices from AI data-center companies.

Nomura: EVE Energy: Overseas customers improve profitability, so why did Nomura raise its earnings forecasts but cut its price target?

A higher contribution from overseas customers improved the third-quarter gross margin; the company raised its 2027 shipment targets, and Nomura consequently revised its earnings forecasts upward. But the tax burden, dilution from the trading business and cash spending on capacity expansion are constraints, while industry policy pressure also prompted Nomura to lower its valuation multiples.